However if you place 100 people with depression into a trial for a new SSRI, you would expect that the only ones to improve would be those whose depression is serotonergic in nature. It wouldn’t help those whose depression is related to dopamine, noradrenaline, NMDARs, cortisol or any of the other common causes of depression.

